FDA to reexamine bendectin data.
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology*; D000818:Animals; D002986:Clinical Trials as Topic; D004025:Dicyclomine; D004319:Doxylamine / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D006345:Heart Septal Defects, Ventricular / Q000139:chemically induced; D006548:Hernia, Diaphragmatic / Q000139:chemically induced; D006801:Humans; D008251:Macaca; D011247:Pregnancy; D011725:Pyridines / Q000009:adverse effects*; D011736:Pyridoxine / Q000009:adverse effects*; D051381:Rats; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D011725:Pyridines; C004454:dicyclomine, doxylamine, pyridoxine drug combination; D004025:Dicyclomine; D004319:Doxylamine; D011736:Pyridoxine